Ardelyx reported $383K in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
TG Therapeutics TGTX:US 1.78M 332K
Abbott ABT:US $ 6908M 160M
Amgen AMGN:US $ 4677M 451M
Ardelyx ARDX:US $ 0.38M 0.65M
Astrazeneca AZN:US 9.11B 169M
Biocept BIOC:US $ 9.61M 5.66M
Corcept Therapeutics CORT:US $ 92.44M 5.03M
Curis CRIS:US $ 1.98M 1M
Opko Health OPK:US $ 85.34M 23.16M
United Therapeutics UTHR:US $ 436M 55.4M